Quantcast
Get breaking news alerts via email

Click here to manage your alerts
U.-developed device may protect against AIDS, pregnancy
Innovation » Dual-purpose intravaginal ring could soon undergo clinical testing.
First Published Mar 05 2014 03:15 pm • Last Updated Mar 05 2014 08:44 pm

A first-of-its-kind birth control and HIV-protection device developed partly at the University of Utah will soon have its first tests in women.

Details of the 90-day intravaginal ring, which releases both birth control and antiretroviral drugs, were published Wednesday in the journal PLOS ONE.

Join the Discussion
Post a Comment

"Women can potentially use a single product as both a contraceptive and to prevent [sexually transmitted diseases]," said Justin Clark, first author on the paper and a doctoral candidate at the U.

Clark was part of a team led by biomedical engineer Patrick Kiser, who has been working on the ring for about five years. Kiser recently left the U. for Northwestern University.

A small clinical trial is slated to begin soon to test the safety of the ring, which will be followed by a larger trial, Clark said.

One of the co-authors on the paper is David Friend, a product development director at CONRAD, a company that develops reproductive health products for developing countries and funded the research through an agreement with the U.S. Agency for International Development.

Though previous studies have shown antiretroviral drugs can prevent HIV infection, they have to be taken every day at high doses, and Friend said a ring could help more people get the medication regularly.

"Products only work when they are used," he said in a statement from Northwestern.

The 5.5 centimeter-ring delivers two drugs. Tenofovir is a common anti-HIV drug that could also protect against herpes, Clark said. Levonorgestrel is the same contraceptive that’s used in a long-lasting intrauterine device (IUD) called Mirena.

To create the ring, scientists had to overcome the different nature of the two drugs — tenofovir is very water-soluble while levonorgestrel isn’t — as well as different dosages. Users need about 1,000 times more tenofovir than the birth-control drug.


story continues below
story continues below

"A lot of engineering has gone into developing the ring," Kiser, the senior author on Wednesday’s study, said in a statement.

The portion of the ring that releases the antiretroviral is made of one kind of polyurethane while the contraceptive section is made from another type, with a third variety in between to keep them separate.

"This is kind of a new idea, leveraging this delivery platform and the clinical evidence that we can prevent infection through the preventive administration of an HIV drug," said Clark. "It’s a long-term effort to get something like this from the bench to the first human study and eventually to market."

lwhitehurst@sltrib.com

Twitter: @lwhitehurst



Copyright 2014 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Top Reader Comments Read All Comments Post a Comment
Click here to read all comments   Click here to post a comment


About Reader Comments


Reader comments on sltrib.com are the opinions of the writer, not The Salt Lake Tribune. We will delete comments containing obscenities, personal attacks and inappropriate or offensive remarks. Flagrant or repeat violators will be banned. If you see an objectionable comment, please alert us by clicking the arrow on the upper right side of the comment and selecting "Flag comment as inappropriate". If you've recently registered with Disqus or aren't seeing your comments immediately, you may need to verify your email address. To do so, visit disqus.com/account.
See more about comments here.
Staying Connected
Videos
Jobs
Contests and Promotions
  • Search Obituaries
  • Place an Obituary

  • Search Cars
  • Search Homes
  • Search Jobs
  • Search Marketplace
  • Search Legal Notices

  • Other Services
  • Advertise With Us
  • Subscribe to the Newspaper
  • Access your e-Edition
  • Frequently Asked Questions
  • Contact a newsroom staff member
  • Access the Trib Archives
  • Privacy Policy
  • Missing your paper? Need to place your paper on vacation hold? For this and any other subscription related needs, click here or call 801.204.6100.